内脏肥胖及其相关疾病的最新进展  

Recent Advances in Visceral Obesity and Related Diseases

作　　者：魏佳佳 缪巍[1] 

机构地区：[1]青海大学附属医院,青海 西宁

出　　处：《临床医学进展》2022年第12期11686-11693,共8页Advances in Clinical Medicine

摘　　要：肥胖是一种病因多面的复杂疾病,具有自身的致残能力、病理生理学和共病,也可定义为是一种与特定身材、性别和年龄的期望值相比,伴随过度脂肪沉积的一种病理状态。而由肥胖导致的相关疾病对人们的工作、生活及心理等均造成了影响,使得人们生活质量进一步下降。随着对肥胖的越来越重视,目前已有多种评估肥胖的测量指标,不同评估指标有着各自的临床参考意义。而目前多项研究表明内脏脂肪面积(visceral fat area, VFA)作为内脏肥胖的测量指标,与一些内科基础疾病及外科手术疾病等有着密切的联系。本文综合目前国内外相关研究,将从肥胖的临床评估指标和与内脏肥胖相关的临床疾病的研究进展两方面作一综述。Obesity is a complex disease of multifaceted aetiology, with its own disabling capacities, pathophysiologies and comorbidities. It can also be defined as a pathological condition accompanied by excessive fat deposition compared to the expectations of a specific body, sex and age. The related diseases caused by obesity have an impact on people’s work, life and psychology, which further reduces people’s quality of life. With the increasing attention to obesity, there are a variety of measurement indicators for assessing obesity, and different evaluation indicators have their own clinical reference significance. At present, a number of studies have shown that visceral fat area (VFA) as a measurement index of visceral obesity is closely related to some basic diseases of internal medicine and surgical diseases. Based on the current relevant research at home and abroad, this article will review the clinical evaluation indicators of obesity and the research progress of clinical diseases related to visceral obesity.

关 键 词：内脏肥胖 VFA 评估指标 最新进展 

分 类 号：R589.2[医药卫生—内分泌]